دورية أكاديمية
Research Progress of Central and Peripheral Corticotropin-Releasing Hormone in Irritable Bowel Syndrome with Comorbid Dysthymic Disorders.
| العنوان: | Research Progress of Central and Peripheral Corticotropin-Releasing Hormone in Irritable Bowel Syndrome with Comorbid Dysthymic Disorders. |
|---|---|
| المؤلفون: | Liang YF; College of Acupuncture and Massage, Anhui University of Chinese Medicine, Hefei, China., Chen XQ; College of Acupuncture and Massage, Anhui University of Chinese Medicine, Hefei, China., Zhang MT; College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China., Tang HY; College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China., Shen GM; College of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine, Hefei, China. |
| المصدر: | Gut and liver [Gut Liver] 2024 May 15; Vol. 18 (3), pp. 391-403. Date of Electronic Publication: 2023 Aug 08. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: Editorial Office of Gut and Liver Country of Publication: Korea (South) NLM ID: 101316452 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2005-1212 (Electronic) Linking ISSN: 19762283 NLM ISO Abbreviation: Gut Liver Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Seoul : Editorial Office of Gut and Liver |
| مواضيع طبية MeSH: | Irritable Bowel Syndrome*/complications , Corticotropin-Releasing Hormone* , Dysthymic Disorder*, Humans ; Comorbidity |
| مستخلص: | Irritable bowel syndrome (IBS) is considered a stress disorder characterized by psychological and gastrointestinal dysfunction. IBS patients not only suffer from intestinal symptoms such as abdominal pain, diarrhea, or constipation but also, experience dysthymic disorders such as anxiety and depression. Studies have found that corticotropin-releasing hormone plays a key role in IBS with comorbid dysthymic disorders. Next, we will summarize the effects of corticotropin-releasing hormone from the central nervous system and periphery on IBS with comorbid dysthymic disorders and relevant treatments based on published literatures in recent years. |
| References: | Gut. 2014 Aug;63(8):1293-9. (PMID: 24153250) Biol Psychiatry. 2009 Jul 1;66(1):76-83. (PMID: 19362706) Life Sci. 2009 Jan 2;84(1-2):18-22. (PMID: 18992758) Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G132-G143. (PMID: 30359082) World J Gastroenterol. 2015 Jun 21;21(23):7181-90. (PMID: 26109804) PLoS One. 2022 Mar 11;17(3):e0264909. (PMID: 35275963) Mol Cell. 2020 Feb 6;77(3):669-680.e4. (PMID: 32004470) J Neurosci. 2019 Feb 6;39(6):1030-1043. (PMID: 30530860) Psychoneuroendocrinology. 2016 Jan;63:178-90. (PMID: 26454419) Int J Mol Sci. 2021 Apr 14;22(8):. (PMID: 33919862) Behav Brain Res. 2018 Feb 15;338:134-142. (PMID: 29080675) Eur J Med Res. 2021 Jan 13;26(1):7. (PMID: 33441166) Neurobiol Stress. 2021 Sep 20;15:100386. (PMID: 34584907) Neurogastroenterol Motil. 2018 Jan;30(1):. (PMID: 28851005) Sci Rep. 2017 May 11;7:46616. (PMID: 28492284) Front Endocrinol (Lausanne). 2018 Feb 12;9:21. (PMID: 29483895) J Psychiatr Res. 2000 May-Jun;34(3):171-81. (PMID: 10867111) Sci Rep. 2020 Nov 26;10(1):20706. (PMID: 33244004) Neuropharmacology. 2020 Jun 15;170:108052. (PMID: 32188569) Endocrinology. 2011 Jan;152(1):126-37. (PMID: 21123435) Vavilovskii Zhurnal Genet Selektsii. 2021 Mar;25(2):216-223. (PMID: 34901719) Neurobiol Stress. 2020 Dec 05;13:100284. (PMID: 33344735) Therap Adv Gastroenterol. 2022 Aug 9;15:17562848221114558. (PMID: 35967918) Neurosci Biobehav Rev. 2015 Nov;58:63-78. (PMID: 26271720) Am J Physiol Gastrointest Liver Physiol. 2018 Mar 1;314(3):G341-G348. (PMID: 29167116) Neurogastroenterol Motil. 2022 Jul;34(7):e14339. (PMID: 35315179) Front Pharmacol. 2021 Mar 19;12:615202. (PMID: 33815103) J Pain. 2021 Oct;22(10):1283-1293. (PMID: 33887444) Gastroenterology. 2011 May;140(5):1597-607. (PMID: 21277851) Curr Neuropharmacol. 2019;17(12):1098-1108. (PMID: 31418663) Eur J Gastroenterol Hepatol. 2022 May 1;34(5):512-517. (PMID: 35275879) Mol Psychiatry. 2017 May;22(5):733-744. (PMID: 27595593) Gastroenterology. 2005 Nov;129(5):1533-43. (PMID: 16285953) Acupunct Med. 2018 Dec;36(6):394-400. (PMID: 30173142) J Physiol. 2014 Dec 1;592(23):5235-50. (PMID: 25260633) Mol Neurobiol. 2021 Nov;58(11):5459-5472. (PMID: 34331656) Mymensingh Med J. 2022 Apr;31(2):458-465. (PMID: 35383767) Physiol Res. 2020 Mar 23;69(2):297-306. (PMID: 32324042) Am J Physiol Gastrointest Liver Physiol. 2009 Jul;297(1):G215-27. (PMID: 19407218) J Neurosci. 2011 Aug 31;31(35):12491-500. (PMID: 21880911) J Neurogastroenterol Motil. 2018 Jan 30;24(1):7-18. (PMID: 29291604) Psychoneuroendocrinology. 2020 Jul;117:104690. (PMID: 32417623) Inflamm Bowel Dis. 2020 Jun 18;26(7):974-984. (PMID: 31944236) Psychopharmacology (Berl). 2021 Jan;238(1):29-40. (PMID: 33231727) Front Psychiatry. 2020 May 15;11:443. (PMID: 32499732) Acupunct Med. 2021 Apr;39(2):135-145. (PMID: 32605385) Curr Mol Pharmacol. 2018;11(1):51-71. (PMID: 28240194) Neurogastroenterol Motil. 2016 Aug;28(8):1172-85. (PMID: 26972279) Brain Behav Immun. 2016 Jul;55:93-104. (PMID: 26743854) J Neurogastroenterol Motil. 2016 Apr 30;22(2):310-20. (PMID: 26645247) Neurogastroenterol Motil. 2022 Sep;34(9):e14377. (PMID: 35411658) Brain Neurosci Adv. 2020 Jul 21;4:2398212820930321. (PMID: 32954002) Stress. 2020 Mar;23(2):201-212. (PMID: 31441348) Neuropharmacology. 2020 Mar 15;165:107926. (PMID: 31883927) Gut. 2009 Nov;58(11):1473-9. (PMID: 19651632) Neurogastroenterol Motil. 2021 Mar;33(3):e14076. (PMID: 33373484) Neuropharmacology. 2019 Aug;154:87-95. (PMID: 30408488) World J Gastroenterol. 2016 Sep 28;22(36):8137-48. (PMID: 27688655) J Neurogastroenterol Motil. 2022 Apr 30;28(2):185-203. (PMID: 35189600) J Dig Dis. 2021 Mar;22(3):143-151. (PMID: 33511763) J Allergy Clin Immunol. 2019 May;143(5):1865-1877.e4. (PMID: 30439403) J Psychiatr Res. 2005 Mar;39(2):173-7. (PMID: 15589565) Brain Res. 2020 Feb 15;1729:146622. (PMID: 31881185) Tech Coloproctol. 2014 Jul;18(7):613-21. (PMID: 24425100) Neurobiol Stress. 2019 Aug 13;11:100191. (PMID: 31467945) J Neurophysiol. 2019 Dec 1;122(6):2636-2642. (PMID: 31800349) Psychosom Med. 2022 Apr 1;84(3):313-324. (PMID: 35067654) Front Psychiatry. 2019 Feb 28;10:101. (PMID: 30890970) Neurogastroenterol Motil. 2005 Jun;17(3):423-32. (PMID: 15916630) Gut. 2006 Feb;55(2):172-81. (PMID: 15985561) Neuron. 2015 Aug 5;87(3):605-20. (PMID: 26212712) BMC Neurol. 2022 May 30;22(1):199. (PMID: 35637446) Psychoneuroendocrinology. 2020 Jan;111:104501. (PMID: 31715444) J Neurosci. 2004 Feb 11;24(6):1305-11. (PMID: 14960601) Gastroenterol Res Pract. 2016;2016:7394924. (PMID: 27478433) Endocr Connect. 2017 Aug;6(6):R99-R120. (PMID: 28710078) Sci Rep. 2020 Aug 12;10(1):13639. (PMID: 32788592) J Clin Endocrinol Metab. 2016 Mar;101(3):1174-80. (PMID: 26751191) J Endocrinol. 2018 Nov 1;239(2):241-252. (PMID: 30139928) Elife. 2019 Aug 14;8:. (PMID: 31411560) Gastroenterol Res Pract. 2019 Oct 13;2019:1759842. (PMID: 31737064) Life Sci. 2019 Dec 15;239:116886. (PMID: 31678286) J Neurogastroenterol Motil. 2022 Apr 30;28(2):173-184. (PMID: 35189599) Zhen Ci Yan Jiu. 2022 Sep 25;47(9):821-9. (PMID: 36153458) Exp Mol Med. 2018 Apr 9;50(4):1-16. (PMID: 29628509) Cell. 2018 Oct 4;175(2):472-487.e20. (PMID: 30146164) J Leukoc Biol. 2017 Dec;102(6):1299-1312. (PMID: 28684600) J Physiol Pharmacol. 2021 Oct;72(5):. (PMID: 35158333) Front Behav Neurosci. 2022 Feb 25;16:808590. (PMID: 35283738) J Neurochem. 2020 Jul;154(2):218-234. (PMID: 32096869) Sci Rep. 2020 Jul 20;10(1):11988. (PMID: 32686762) Molecules. 2020 Sep 20;25(18):. (PMID: 32962285) Chemosphere. 2022 Jan;287(Pt 3):132170. (PMID: 34826932) J Physiol Pharmacol. 2009 Dec;60 Suppl 7:33-46. (PMID: 20388944) Am J Gastroenterol. 2020 Dec;115(12):2047-2059. (PMID: 32740086) Exp Ther Med. 2019 Apr;17(4):3077-3082. (PMID: 30936979) Front Neurosci. 2021 Sep 03;15:721822. (PMID: 34539337) Cell Mol Neurobiol. 2022 Mar;42(2):389-417. (PMID: 33030712) Trends Psychiatry Psychother. 2020 Jun;42(2):195-206. (PMID: 32696892) J Comp Neurol. 2005 Jan 17;481(3):284-98. (PMID: 15593376) Exp Neurol. 2021 Nov;345:113841. (PMID: 34390704) Z Vitam Horm Fermentforsch. 1957;9(1-2):74-96. (PMID: 13531578) Aliment Pharmacol Ther. 2014 Aug;40(4):392-402. (PMID: 24943480) Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2018 Mar;162(1):1-9. (PMID: 29358788) Neurogastroenterol Motil. 2019 Mar;31(3):e13500. (PMID: 30393913) Peptides. 2022 Jan;147:170705. (PMID: 34822913) PLoS One. 2012;7(6):e39935. (PMID: 22768175) Acta Psychiatr Scand. 2019 Jan;139(1):56-67. (PMID: 30229855) Acta Neuropathol. 2021 Dec;142(6):1045-1064. (PMID: 34536123) Mayo Clin Proc. 2018 Dec;93(12):1858-1872. (PMID: 30522596) Neuropharmacology. 2010 Sep;59(3):160-6. (PMID: 20470804) Transl Psychiatry. 2021 Jul 7;11(1):378. (PMID: 34234103) Zhen Ci Yan Jiu. 2019 May 25;44(5):347-51. (PMID: 31155867) Neurosci Biobehav Rev. 2019 Aug;103:50-59. (PMID: 31212019) Circ J. 2019 Jan 25;83(2):261-266. (PMID: 30584229) Mol Med Rep. 2018 Jun;17(6):8167-8172. (PMID: 29693127) Neurogastroenterol Motil. 2012 Mar;24(3):201-5. (PMID: 22316289) Science. 1981 Sep 18;213(4514):1394-7. (PMID: 6267699) Front Cell Neurosci. 2019 Jul 02;13:290. (PMID: 31312123) |
| فهرسة مساهمة: | Keywords: Corticotropin-releasing hormone; Dysthymic disorder; Irritable bowel syndrome; Review |
| تواريخ الأحداث: | Date Created: 20230808 Date Completed: 20240514 Latest Revision: 20240807 |
| رمز التحديث: | 20240807 |
| مُعرف محوري في PubMed: | PMC11096901 |
| DOI: | 10.5009/gnl220346 |
| PMID: | 37551453 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2005-1212 |
|---|---|
| DOI: | 10.5009/gnl220346 |